Naturewise Biotech & Medicals (ROCO:4732) Total Liabilities : NT$57.0 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Naturewise Biotech & Medicals Total Liabilities?

Naturewise Biotech & Medicals's Total Liabilities for the quarter that ended in Dec. 2024 was NT$57.0 Mil.

Naturewise Biotech & Medicals's quarterly Total Liabilities declined from Dec. 2023 (NT$64.89 Mil) to Jun. 2024 (NT$58.98 Mil) and declined from Jun. 2024 (NT$58.98 Mil) to Dec. 2024 (NT$57.03 Mil).

Naturewise Biotech & Medicals's annual Total Liabilities increased from Dec. 2022 (NT$51.09 Mil) to Dec. 2023 (NT$64.89 Mil) but then declined from Dec. 2023 (NT$64.89 Mil) to Dec. 2024 (NT$57.03 Mil).

Naturewise Biotech & Medicals Total Liabilities Historical Data

The historical data trend for Naturewise Biotech & Medicals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturewise Biotech & Medicals Total Liabilities Chart

Naturewise Biotech & Medicals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

59.93

80.22

51.09

64.89

57.03

Naturewise Biotech & Medicals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															51.09	62.34	64.89	58.98	57.03

Naturewise Biotech & Medicals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Naturewise Biotech & Medicals's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	50.438	+	(0.056	+	6.539
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	57.0

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	840.59	-	783.557
	=	57.0

Naturewise Biotech & Medicals's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	50.438	+	(0.056	+	6.539
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	57.0

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	840.59	-	783.557
	=	57.0

Naturewise Biotech & Medicals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Naturewise Biotech & Medicals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Naturewise Biotech & Medicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Naturewise Biotech & Medicals Corp (ROCO:4732) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 36, Bade Road, 6th Floor, Section 3, Songshan District, Taipei, TWN, 105

Website

https://www.naturewise.com.tw

Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.

Naturewise Biotech & Medicals Headlines

No Headlines